November 2014 - The Reporter

Nicolaas Geurs, D.D.S., M.S., inaugural holder of UAB's Weatherford-Palcanis Endowed Professorship in Dentistry and the Dental Alumni-Joseph F. Volker Chair of Clinical Dentistry, has been selected as the next dean of the UAB School of Dentistry following a national search. He will begin his new role June 1.

Published in Leadership
The U.S. Department of Labor has announced a change to the criteria for determining employees’ status as nonexempt (paid bi-weekly) or exempt (paid monthly) under the Fair Labor Standards Act. This is not a UAB decision; it is a federal law all employers must follow. 
Published in Take Note
Annalise Sorrentino, M.D., professor in the Department of Pediatrics, will take on the role Oct. 1, 2024. She replaces Frank Messina, Ph.D., professor in the Collat School of Business, who has served as UAB’s FAR since 2008 and is retiring from UAB at the end of September.
Published in Faculty Appointments
Johnny W. Scott, M.D., Ph.D., professor of nuclear medicine in the Department of Radiology, graduated from the School of Medicine in 1975 and has been a member of the faculty since 1978. Last month, he was honored for 45 years of service.
Published in Awards & Honors

Daryl Green, Ph.D., chief of UAB Police and AVP of Public Safety, has been on campus for 20 months — here is how the force has changed under his watch and what he wants to share with all UAB employees.

Published in Campus Safety
The UAB Police and Public Safety Department held its first promotional ceremony on Jan. 3, 2024, recognizing officers and employees who have moved up the ranks for their dedication and committed service to the UAB Community.
Published in Campus Safety
You may be eligible to participate in a research study: If you are a healthy female, between age of 18-50, still having a regular menstrual cycle & you are NOT on hormonal birth control (birth control pills or shots (i.e. Depo shot) or IUD, like Mirena). And, if you are willing to undergo an endometrial biopsy procedure and blood draw. Participants will be compensated a total of $200. Only requires 2 visits.

For information, call us at 205-934-5498 or email Stephanie Ford at smford@uabmc.edu
Published in Clinical Trials

The Green Labs and Rheaply programs at UAB have earned a Department of Energy Better Practice Awards honor — one of only two universities to receive the award. Another recognition brings pro bono consulting on electrification of Blazer Express.

Published in Sustainability
On May 6, join a virtual 30-minute session exploring the Career Goals feature in LinkedIn Learning, an online learning resource platform available at no cost to all benefit-eligible employees at UAB. Register today.
Published in Learning & Development

A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)

TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.

  • Are aged 18 years or older
  • Have type 2 diabetes
  • Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
  • Have a BMI of 25 or more
  • Have HbA1c levels of 7.0% to 10.5%

To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
Published in Clinical Trials
Page 1 of 346